¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ±â±âº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¿¹Ãø(2023-2030³â)
Cardiac Arrhythmia Monitoring Devices Market, By Device, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1425005
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 287 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,612,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,598,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,017,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 71¾ï 9,640¸¸ ´Þ·¯°¡ µÇ¾î, 2023³âºÎÅÍ 2030³â¿¡ °ÉÃÄ CAGR 7.7%·Î È®´ëÇÒ Àü¸ÁÀÔ´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ½ÃÀå ¿ªÇÐ

ƯÈ÷ ³ëÀÎ ºÎÁ¤¸Æ ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ¿ø°Ý ½ÉÀå Áø´ÜÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ Àü¸Á

ƯÈ÷ ³ëÀÎ ºÎÁ¤¸Æ ȯÀÚ¿¡ ´ëÇÑ ¿ø°Ý ½ÉÀå Áø´ÜÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¿ø°Ý ½ÉÀüµµ´Â ºñ¿ë È¿À²ÀûÀÎ ¸ð´ÏÅ͸µ Àåºñ¸¦ Á¦°øÇϸç Coala Life¿Í °°Àº ±â¾÷Àº ȯÀÚ Á÷Åë ¿ø°Ý ½ÉÀüµµ ¼­ºñ½º¸¦ ½ÃÀÛÇϰí ÀÖ½À´Ï´Ù. ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±âÀÇ ÆíÀǼº°ú È޴뼺Àº ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºÎÁ¤¸Æ °ËÃâÀ» À§ÇÑ 4G ÈÞ´ëÆù ¿¬°á ±â´ÉÀ» °®Ãá RhythMedixÀÇ ¿þ¾î·¯ºí ½ÅÇü ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ¸ð´ÏÅÍ¿Í °°Àº Çõ½ÅÀº À¯»çÇÑ ÈÞ´ë¿ë ½ÉÀå ¸ð´ÏÅÍ °³¹ß¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¿ø°Ý ÃøÁ¤ ±â¼úÀÇ º¸±ÞÀÌ ´Ê¾îÁö°í ¿ø°Ý ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±âÀÇ ºñ¿ëÀÌ ³ôÀº °ÍÀÌ ½ÃÀå ¼ºÀåÀÇ ÀúÇØ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®·Â

¿ì¸®ÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â)¿¡ ¾à 7.7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ƯÈ÷ ½ÉÀå ºÎÁ¤¸ÆÀÇ ³ëÀΠȯÀÚ¿¡ ´ëÇÑ ¿ø°Ý ½ÉÀå °Ë»çÀÇ Ã¤¿ë Áõ°¡·Î ÀÎÇØ »ó´çÇÑ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â±âº°·Î, ȦÅÍ ¸ð´ÏÅ͸µ ±â±â ºÐ¾ß´Â 2022³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸¿©ÁÙ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î º´¿ø ¹× Ŭ¸®´ÐÀº 2022³â ÁÖ¿ä ºÎ¹®À̾ú½À´Ï´Ù.

Áö¿ªº°·Î ºÏ¹Ì´Â 2022³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº ±â±âº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°·Î ±¸ºÐµË´Ï´Ù.

±â±âº°·Î ½ÃÀåÀº 4°³ÀÇ ºÎ¹®À¸·Î ³ª´µ¾î À̺¥Æ® ¸ð´ÏÅ͸µ ±â±â, ¿¬¼Ó ¸®µë ¸ð´ÏÅ͸µ ±â±â, ȦÅÍ ¸ð´ÏÅ͸µ ±â±â ¹× ±âŸ ±â±âÀÔ´Ï´Ù. ȦÅÍ ¸ð´ÏÅ͸µ ±â±â ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÏ°í ¿¹Ãø ±â°£ µ¿¾È ÁÖµµÀû ÁöÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ȦÅÍ ¸ð´ÏÅ͸µ ±â±â´Â ȯÀÚÀÇ »ê¹ßÀû Áõ»óÀ» Àå±â°£¿¡ °ÉÃÄ È¿°úÀûÀ¸·Î Áø´ÜÇÒ ¼ö Àֱ⠶§¹®¿¡ ½ÃÀåÀÇ Áß½ÉÀûÀÎ Á¸Àç°¡ µÇ¾ú½À´Ï´Ù. °Ô´Ù°¡ º¸´Ù ºü¸£°í °£ÆíÇÑ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇϱ⠶§¹®¿¡ ȯÀÚÀÇ ¾îµåÈ÷¾î·±½º°¡ ³ô¾ÆÁö°í Ä¡·á ¼ºÀûÀÌ Çâ»óµË´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°·Î 5°³ÀÇ ºÎ¹®À¸·Î ºÐ·ùµÈ´Ù : º´¿ø ¹× Áø·á¼Ò, Áø´Ü¼¾ÅÍ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á, ±âÀ¯Çü´Ï´Ù. ÀÌ Áß, ƯÈ÷ º´¿ø ¹× Áø·á¼Ò ºÎ¹®ÀÌ 2022³âÀÇ ¼öÀÍ Á¡À¯À²·Î ¸®µåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ¼ºÀåÀº ½ÉÀå ºÎÁ¤¸Æ ¼¼°èÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ­ Àα¸ Áõ°¡°¡ Ä¡·á¸¦À§ÇÑ ÀÔ¿øÀ» ÃËÁøÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - Áö¸®Àû ÅëÂû

Áö¿ªÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¢ Áö¿ªÀ¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Á¦°øÇÏ´Â ±¹°¡¿¡ ÀÇÇØ ´õ ³ª´¹´Ï´Ù. ºÏ¹Ì´Â Á¤±³ÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ÃÖ÷´Ü ½ÉÇ÷°ü Ä¡·á°¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áúº´´ëÃ¥¿¹¹æ¼¾ÅÍ(CDC)¿¡ µû¸£¸é 2030³â±îÁö 1,210¸¸¸íÀÇ ¹Ì±¹ÀÎÀÌ ½É¹æ¼¼µ¿(AFib)¿¡ ½Ã´Þ¸®°Ô µË´Ï´Ù. ½É¹æ¼¼µ¿(AFIb)ÀÌ È¯ÀÚ Áý´Ü¿¡¼­ °¡Àå ºó¹øÇÏ°Ô Áø´ÜµÇ´Â ½ÉÀå ºÎÁ¤¸ÆÀÓÀ» °¨¾ÈÇϸé, ÀÌ ¼öÄ¡´Â ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ¼ö¿ä°¡ Áõ°¡ÇÒ °¡´É¼ºÀÌ ³ô´Ù´Â °ÍÀ» ½Ã»çÇÕ´Ï´Ù., ³ª¾Æ°¡¼­´Â ½ÃÀåÀÇ È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÑ´Ù°í »ý°¢µË´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - °æÀï ±¸µµ -

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ºÐ¾ßÀÇ ±â¾÷µéÀº ±â¼ú Áøº¸¿Í ȯÀÚ °ü¸® °³¼±¿¡ Àü³äÇϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ÄèÀû¼ºÀ» ³ôÀ̱â À§ÇÑ ±â±âÀÇ ¼ÒÇüÈ­³ª ¼ö¸íÀÌ ±ä ÀÓº£µðµå ±â±âÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀÇ °­È­´Â ¿ì¼±¼øÀ§À̸ç, ÀÇ·á Á¦°ø¾÷ü¿¡°Ô ½Ç½Ã°£ µ¥ÀÌÅÍ Àü¼ÛÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ ºÐ¼®°ú ÀΰøÁö´ÉÀÇ ÅëÇÕÀº ºÎÁ¤¸ÆÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, º¸´Ù È¿°úÀûÀΠȯÀÚ °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ¾÷°è Á¶»ç

Á¦5Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå »óȲ

Á¦7Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ±â±âº°

Á¦8Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÃÖÁ¾ »ç¿ëÀÚº°

Á¦9Àå ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - Áö¿ªº°

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® - ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ¾÷°è

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Cardiac Arrhythmia Monitoring Devices Market size was valued at USD 7,196.4 Million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

Cardiac arrhythmia monitoring devices are medical devices designed to monitor and record the electrical activity of the heart to detect and diagnose cardiac arrhythmias. These devices play a crucial role in the management and treatment of various heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, and bradycardia. They help healthcare professionals identify irregular heart rhythms, assess their severity, and determine the appropriate treatment or intervention.

Cardiac Arrhythmia Monitoring Devices Market- Market Dynamics

The increasing adoption of telecardiology, especially for elderly patients with cardiac arrhythmia is expected to propel the market demand

The increasing adoption of telecardiology, especially for elderly patients with cardiac arrhythmia, is a major growth driver. Telecardiology offers cost-effective monitoring devices, with companies like Coala Life launching direct-to-patient telecardiology services. The convenience and portability of cardiac arrhythmia monitoring devices are driving market growth. Innovations such as RhythMedix's wearable novel cardiac telemetry monitor with 4G cellular connectivity for arrhythmia detection have fueled the development of similar portable cardiac monitors. However, poor adoption of telemetry technology in emerging markets and the high cost of remote cardiac arrhythmia monitoring devices are hindrances to market growth.

Cardiac Arrhythmia Monitoring Devices Market- Key Insights

As per the analysis shared by our research analyst, the global Cardiac Arrhythmia Monitoring Devices Market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2023-2030)

The Cardiac Arrhythmia Monitoring Devices Market is projected to grow at a significant rate driven by the increasing adoption of telecardiology, especially for elderly patients with cardiac arrhythmia.

Based on Device, the Holter monitoring devices segment was predicted to show maximum market share in the year 2022

Based on End User, the hospitals and clinics was the leading Segment in 2022

On the basis of region, North America was the leading revenue generator in 2022

Cardiac Arrhythmia Monitoring Devices Market- Segmentation Analysis:

The Global Cardiac Arrhythmia Monitoring Devices Market is segmented on the basis of Device, By End User, and Region.

Based on the Device, the market is divided into four segments: Event Monitoring Devices, Continuous Rhythm Monitoring Devices, Holter Monitoring Devices, Other Devices. Holter monitoring devices segment generated the highest revenue, and it is expected to maintain its leading position throughout the forecast period. Anticipated significant growth is on the horizon for the Holter monitoring devices segment as these devices have taken center stage in the market due to their ability to effectively diagnose sporadic symptoms in patients over extended durations. Moreover, they provide swifter and more convenient monitoring, resulting in heightened patient adherence and improved treatment outcomes.

The market is categorized by End User into five segments: Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others. Among these, notably, the hospitals and clinics segment took the lead of the revenue share in 2022. Furthermore, this segment is expected to experience substantial growth in the forecast period. This growth can be attributed to the rising global prevalence of cardiac arrhythmia and the increasing aging population, which is driving hospital admissions for treatment.

Cardiac Arrhythmia Monitoring Devices Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period because sophisticated healthcare infrastructure and cutting-edge cardiovascular treatments are becoming more widely used. By 2030, 12.1 million Americans, according to the Centers for Disease Control and Prevention (CDC), will suffer from atrial fibrillation (AFib). Given that atrial fibrillation (AFIb) is the most often diagnosed cardiac arrhythmia in the patient population, these figures suggest that there will likely be a rise in demand for cardiac arrhythmia monitoring devices, which will in turn fuel the expansion of the market.

Cardiac Arrhythmia Monitoring Devices Market- Competitive Landscape:

Companies in the field of cardiac arrhythmia monitoring are dedicated to advancing the technology and improving patient care. They focus on miniaturizing devices for greater patient comfort and developing implantable devices with longer lifespans. Enhancing remote monitoring capabilities is a priority, allowing for real-time data transmission to healthcare providers. Additionally, the integration of data analytics and artificial intelligence plays a crucial role in the rapid and accurate diagnosis of arrhythmias, enabling more effective patient management.

Recent Developments:

In June 2023, the first implant of its BIOMONITOR IV implanted cardiac monitor (ICM) has taken place worldwide, according to BIOTRONIK, a pioneer in implantable medical device technology. Luigi Di Biase, MD, PhD, Director of Arrhythmia Services, Section Head of Electrophysiology, and Professor of Medicine at Montefiore Einstein in the Bronx, New York, performed the procedure. The next development in heart monitoring technology is this first implant.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET KEY PLAYERS

GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE

GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER

GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION

Table of Contents

1. Cardiac Arrhythmia Monitoring Devices Market Overview

2. Executive Summary

3. Cardiac Arrhythmia Monitoring Devices Key Market Trends

4. Cardiac Arrhythmia Monitoring Devices Industry Study

5. Cardiac Arrhythmia Monitoring Devices Market: COVID-19 Impact Analysis

6. Cardiac Arrhythmia Monitoring Devices Market Landscape

7. Cardiac Arrhythmia Monitoring Devices Market - By Device

8. Cardiac Arrhythmia Monitoring Devices Market - By End User

9. Cardiac Arrhythmia Monitoring Devices Market- By Geography

10. Key Vendor Analysis- Cardiac Arrhythmia Monitoring Devices Industry

11. 360 Degree Analyst View

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â